[2] [2] PANDYA C, PANICKER R R, SENJALIYA P, et al. Designing and synthesis of phosphine derivatives of Ru3(CO)12 - Studies on catalytic isomerization of 1-alkenes［J］. Inorganica Chimica Acta, 2021, 518: 120211.

[4] [4] STEPANENKO O V, STEPANENKO O V, SHPIRONOK O G, et al. Near-infrared markers based on bacterial phytochromes with phycocyanobilin as a chromophore［J］. International Journal of Molecular Sciences, 2019, 20(23): 6067.

[5] [5] ABU SHAMMA A, ABU ALI H, KAMEL S. Synthesis, characterization and biological properties of mixed ligand complexes of cobalt(II/III) valproate with 2, 9-dimethyl-1, 10-phenanthroline and 1, 10-phenanthroline［J］. Applied Organometallic Chemistry, 2018, 32(1): e3904.

[8] [8] GROSSMAN S, GRUNNET M, et al. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: eastern cooperative oncology group trial 2394［J］. Journal of Clinical Oncology, 2003, 21(8): 1485-1491.

[9] [9] LYNCH T J, BONDARENKO I, LUFT A, et al. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study［J］. Journal of Clinical Oncology, 2012, 30(17): 2046-2054.

[10] [10] SALTZ L B, CLARKE S, DAZ-RUBIO E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study［J］. Journal of Clinical Oncology, 2008, 26(12): 2013-2019.

[11] [11] JOMAA M Y, ALTAF M, AHMAD S, et al. Synthesis, spectroscopic characterization and in vitro anticancer activity of new platinum(II) complexes with some thione ligands in the presence of triethylphosphine［J］. BioMetals, 2017, 30(5): 787-795.

[13] [13] SHELDRICK G. SHELX-84: a program system for crystal structure solution and refinement［J］. Acta Crystallographica Section A Foundations of Crystallography, 1984, 40(a1): C440.

[14] [14] ZAREIAN-JAHROMI S, MANSOURI-TORSHIZI H. Synthesis, characterization, DNA and HSA binding studies of isomeric Pd (II) antitumor complexes using spectrophotometry techniques［J］. Journal of Biomolecular Structure and Dynamics, 2018, 36(5): 1329-1350.

[15] [15] ALI YASREBI S, TAKJOO R, RIAZI G H. HSA-interaction studies of uranyl complexes of alkyl substituted isothiosemicarbazone［J］. Journal of Molecular Structure, 2019, 1193: 53-61.

[16] [16] SHAHRAKI S, HEYDARI A, DELARAMI H S, et al. Preparation, characterization and comparison of biological potency in two new Zn(II) and Pd(II) complexes of butanedione monoxime derivatives［J］. Journal of Biomolecular Structure and Dynamics, 2020, 38(4): 997-1011.

[17] [17] MA A Q, CHEN H Q, CUI Y H, et al. Metalloporphyrin complex-based nanosonosensitizers for deep-tissue tumor theranostics by noninvasive sonodynamic therapy［J］. Small, 2019, 15(5): e1804028.

[20] [20] CHAVES O A, MENEZES L B, IGLESIAS B A. Multiple spectroscopic and theoretical investigation of meso-tetra-(4-pyridyl)porphyrin-ruthenium(II) complexes in HSA-binding studies. Effect of Zn(II) in protein binding［J］. Journal of Molecular Liquids, 2019, 294: 111581.

[21] [21] ABYAR F, TABRIZI L. New multinuclear Scaffold molybdocene-gold lidocaine complex: DNA/HSA binding, molecular docking, cytotoxicity and mechanistic insights［J］. Journal of Biomolecular Structure and Dynamics, 2019, 37(13): 3366-3378.

[22] [22] ZENG Z F, HUANG Q P, CAI J H, et al. Synthesis, characterization, DNA/HSA interactions, and anticancer activity of two novel copper(II) complexes with 4-chloro-3-nitrobenzoic acid ligand［J］. Molecules, 2021, 26(13): 4028.